Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)
about
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Cisplatin, raltitrexed, levofo ...... erative Oncology Group (SICOG)
@en
Cisplatin, raltitrexed, levofo ...... erative Oncology Group (SICOG)
@nl
type
label
Cisplatin, raltitrexed, levofo ...... erative Oncology Group (SICOG)
@en
Cisplatin, raltitrexed, levofo ...... erative Oncology Group (SICOG)
@nl
prefLabel
Cisplatin, raltitrexed, levofo ...... erative Oncology Group (SICOG)
@en
Cisplatin, raltitrexed, levofo ...... erative Oncology Group (SICOG)
@nl
P2093
P50
P356
P1433
P1476
Cisplatin, raltitrexed, levofo ...... erative Oncology Group (SICOG)
@en
P2093
F Caponigro
F Rivellini
L Manzione
N Mozzillo
P304
P356
10.1023/A:1008339428733
P577
2000-05-01T00:00:00Z